GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

OLIG2 inhibitor B01   Click here for help

GtoPdb Ligand ID: 14253

Compound class: Synthetic organic
Comment: B01 is an OLIG2 transcription factor inhibitor [1]. It was developed to explore the anti-glioma potential of OLIG2 inhibition.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 91.87
Molecular weight 298.13
XLogP -0.17
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=C(C(=C1)Cl)Cl)NC(=O)NC2=CC(=NC=N2)N
Isomeric SMILES NC1=CC(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)=NC=N1
InChI InChI=1S/C11H9Cl2N5O/c12-7-2-1-6(3-8(7)13)17-11(19)18-10-4-9(14)15-5-16-10/h1-5H,(H4,14,15,16,17,18,19)
InChI Key XORVGXRQCYTIJZ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Xu Z, Xi Y, Guo Y, Wang C, Shi Y, Sun D, Zhang Y, Ye F, Xu X, Wang X. (2025)
Discovery of novel pyrimidine-4,6-diamine-based OLIG2 inhibitors as potent anti-glioblastoma agents.
Eur J Med Chem, 298: 118009. [PMID:40763665]